6042. Meprobamate tablets. (F.D.C. No. 42475. S. Nos. 35-394 P, 35-397 P.) INFORMATION FILED: 10-9-59, E. Dist. Pa., against Jan Laboratories, Phila- delphia, Pa., a partnership, Jerry Levin, a partner in the partnership, and Edward Lavin, a salesman for the partnership. ALLEGED VIOLATION : The information alleged that, on 4-29-58, while a number of meprobamate tablets were being held for sale after shipment in interstate commerce, Jan Laboratories and Jerry Levin caused a number of the tablets to be repacked into a bottle and did sell and dispose of the bottle at Phila- delphia, Pa., which acts of causing the repacking, sale, and disposal resulted in the drug being misbranded within the meaning of 502 (a). The information alleged also that all of the defendants, on 4-30-58, caused to be shipped from Philadelphia, Pa., to Pleasantville, N. J., a number of tablets which were in violation of 505(a), and which were misbranded under 502(a). CHARGE: 502(a)-The label statement "For Investigational and Export Use Only" was false and misleading in that the article was not for investigational and export use only; and 505(a)-the article was a new drug which may not be introduced into interstate commerce, since an application filed pursuant to 505 (b) was not effective with respect to such drug. PLEA : Nolo contendere. DISPOSITION : 3-22-60. Partnership-probation for 5 years; Levin-$2,250 fine, 6 months jail sentence which was suspended, and probation for 5 years; Lavin-$1,250 fine, 4 months jail sentence which was suspended, and proba- tion for 5 years. DRUGS REQUIRING CERTIFICATE OR RELEASE, FOR WHICH NONE HAD BEEN ISSUED DRUGS FOR HUMAN USE